Every day, we see the strength.
Every week, we see Hope.
Every month, we need to make lupus visible.
Awareness is a continuous journey of compassion and support.
Thank you Washington School
Every day, we see the strength.
Every week, we see Hope.
Every month, we need to make lupus visible.
Awareness is a continuous journey of compassion and support.
Thank you Washington School
Many excellent sessions and abstracts, especially appreciated the multiple sessions on CNS lupus and cognitive impairment - an area of importance for patients with lupus.
Many excellent sessions and abstracts, especially appreciated the multiple sessions on CNS lupus and cognitive impairment - an area of importance for patients with lupus.
#LupusAwarenessMonth #LupusAwareness
@lupuschat.bsky.social @caringforlupus.bsky.social @michiganlupus.bsky.social @ghlforg.bsky.social
#LupusAwarenessMonth #LupusAwareness
@lupuschat.bsky.social @caringforlupus.bsky.social @michiganlupus.bsky.social @ghlforg.bsky.social
Kidney or Liquid Biopsy for Assessing Lupus Nephritis Activity
Andrea Fava
John Hopkins University School of Medicine, Division of Rheumatology, Baltimore, United States of America
@ladaorg.bsky.social
@lupuschat.bsky.social
#Lupus2025
#Lupuschat
#Lupus
Kidney or Liquid Biopsy for Assessing Lupus Nephritis Activity
Andrea Fava
John Hopkins University School of Medicine, Division of Rheumatology, Baltimore, United States of America
@ladaorg.bsky.social
@lupuschat.bsky.social
#Lupus2025
#Lupuschat
#Lupus
I learned so much, connected with global experts & advocates.
Your support amplifies our stories, fuels research & drives change
#Lupus2025
@lupuschat.bsky.social @caringforlupus.bsky.social @annezab.bsky.social @alhkim.bsky.social
I learned so much, connected with global experts & advocates.
Your support amplifies our stories, fuels research & drives change
#Lupus2025
@lupuschat.bsky.social @caringforlupus.bsky.social @annezab.bsky.social @alhkim.bsky.social
@lupuschat.bsky.social @caringforlupus.bsky.social @annezab.bsky.social @alhkim.bsky.social
@lupuschat.bsky.social @caringforlupus.bsky.social @annezab.bsky.social @tiffanyandlupus.bsky.social
Kathleen Arntsen,
Dina Thachet, Kaamilah Gilyard, Whiney Carter, David Arntsen,
Autumn Austin
@lupuschat.bsky.social @caringforlupus.bsky.social @annezab.bsky.social @tiffanyandlupus.bsky.social
Kathleen Arntsen,
Dina Thachet, Kaamilah Gilyard, Whiney Carter, David Arntsen,
Autumn Austin
Dr. Victoria Werth is a Professor of Dermatology and Medicine at the Perelman School of Medicine at the University of Pennsylvania
@ladaorg.bsky.social
@lupuschat.bsky.social
#Lupus2025
#Lupuschat
#Lupus
Dr. Victoria Werth is a Professor of Dermatology and Medicine at the Perelman School of Medicine at the University of Pennsylvania
@ladaorg.bsky.social
@lupuschat.bsky.social
#Lupus2025
#Lupuschat
#Lupus
Meet-the-Professor Session: Refractory Skin Manifestation
Dr. Cheryl Rosen is a dermatologist at Toronto Western Hospital.
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Meet-the-Professor Session: Refractory Skin Manifestation
Dr. Cheryl Rosen is a dermatologist at Toronto Western Hospital.
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Clinical Scientific Session: Update on Lupus Nephritis, Novel Approaches in LN
"It is important to treat the kidney Holistically"
@ladaorg.bsky.social
@lupuschat.bsky.social
#Lupus2025
#Lupuschat
#Lupus
Clinical Scientific Session: Update on Lupus Nephritis, Novel Approaches in LN
"It is important to treat the kidney Holistically"
@ladaorg.bsky.social
@lupuschat.bsky.social
#Lupus2025
#Lupuschat
#Lupus
🔺 VMS (Vasomotor symptoms) can have severe effects on QOL
🔺concerning symptoms: night sweats, vaginal dryness, mood disorders, libido loss, etc
🔺Recommended therapy: Fezolinetant
#LUPUS2025
@ladaorg.bsky.social
@lupuschat.bsky.social
🔺 VMS (Vasomotor symptoms) can have severe effects on QOL
🔺concerning symptoms: night sweats, vaginal dryness, mood disorders, libido loss, etc
🔺Recommended therapy: Fezolinetant
#LUPUS2025
@ladaorg.bsky.social
@lupuschat.bsky.social
There seems to be no available data on fertility or family planning for men with lupus. So the presenter is sharing data for men w/ arthritis.
#LUPUS2025
@ladaorg.bsky.social #LADAOrg
#LupusChat
There seems to be no available data on fertility or family planning for men with lupus. So the presenter is sharing data for men w/ arthritis.
#LUPUS2025
@ladaorg.bsky.social #LADAOrg
#LupusChat
#LUPUS2025 #LADAOrg
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025 #LADAOrg
@ladaorg.bsky.social
@lupuschat.bsky.social
Helen Masson:
O026 - MULTI-OMIC INTEGRATION REVEALS THREE MOLECULAR SUBTYPES WITH DISTINCT IMMUNOLOGICAL PHENOTYPES IN A COHORT OF 722 SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS (ID 740)
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#LupusChat
#Lupus
Helen Masson:
O026 - MULTI-OMIC INTEGRATION REVEALS THREE MOLECULAR SUBTYPES WITH DISTINCT IMMUNOLOGICAL PHENOTYPES IN A COHORT OF 722 SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS (ID 740)
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#LupusChat
#Lupus
Richard A Furie:
O025 - RESULTS FROM THE REGENCY TRIAL ASSESSING EFFICACY AND SAFETY OF OBINUTUZUMAB IN ACTIVE LUPUS NEPHRITIS (ID 750)
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Richard A Furie:
O025 - RESULTS FROM THE REGENCY TRIAL ASSESSING EFFICACY AND SAFETY OF OBINUTUZUMAB IN ACTIVE LUPUS NEPHRITIS (ID 750)
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Abstract Concurrent Session 04: Advancing Lupus Therapies and Insights
0024 - ENDOTHELIAL BRD4 PARTICIPATES IN THE DEVELOPMENT OF LUPUS NEPHRITIS (ID 733)
Authors: Wang X., Zhang W., Ni X.
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Abstract Concurrent Session 04: Advancing Lupus Therapies and Insights
0024 - ENDOTHELIAL BRD4 PARTICIPATES IN THE DEVELOPMENT OF LUPUS NEPHRITIS (ID 733)
Authors: Wang X., Zhang W., Ni X.
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Breaking Barriers: Advancing Disease Modification and Early Intervention in SLE & LN with Patient-Centered Strategies
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Breaking Barriers: Advancing Disease Modification and Early Intervention in SLE & LN with Patient-Centered Strategies
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Breaking Barriers: Advancing Disease Modification and Early Intervention in SLE & LN with Patient-Centered Strategies
Professor Karen Costenbader
Director, Lupus Program, Brigham
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
Breaking Barriers: Advancing Disease Modification and Early Intervention in SLE & LN with Patient-Centered Strategies
Professor Karen Costenbader
Director, Lupus Program, Brigham
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
Stacy Payne Ardoin:
Targets in CV Disease in cSLE
Dr. Ardoin's clinical research focuses on optimal treatment and long-term outcomes of adults and children with lupus.
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Stacy Payne Ardoin:
Targets in CV Disease in cSLE
Dr. Ardoin's clinical research focuses on optimal treatment and long-term outcomes of adults and children with lupus.
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#Lupuschat
#Lupus
Pediatric Scientific Session: Outcomes and Targets in Children with SLE
Andrea M Knight:
Targets for the Management of NPSLE (Including Mental Health)
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#LupusChat
#Lupus
Pediatric Scientific Session: Outcomes and Targets in Children with SLE
Andrea M Knight:
Targets for the Management of NPSLE (Including Mental Health)
@ladaorg.bsky.social
@lupuschat.bsky.social
#LUPUS2025
#LupusChat
#Lupus